Credits: 5 CME/CE credits.
Course Access: 12 months
Bulk pricing is available! Click here to learn more.
The Pennsylvania Medical Marijuana Program Required Course Bundle has been approved by the Pennsylvania Department of Health and satisfies the Pennsylvania educational requirements to become a practitioner with the Pennsylvania Medical Marijuana Program.
This bundle introduces the reader to the endocannabinoid system and its interaction with the components of the cannabis plant, and addresses various aspects of medical marijuana, including administration, therapeutic use, drug metabolism, physiologic and cognitive effects, potential risks, and drug interactions.
The use of marijuana in obstetric patients, pediatric patients, adolescent patients and elderly patients is discussed in detail. Important considerations for patients with ischemic heart disease, hepatic disease, psychotic illness, and those with a history of drug dependence are provided.
This course bundle also addresses the use of cannabidiol (CBD) in clinical care, and the information will assist clinicians in effectively treating and counseling CBD consumers. The physiological effects of CBD, CBD drug interactions, CBD’s side effects, and the conditions for which CBD has been shown by evidence-based clinical studies to be efficacious are all discussed in this course bundle.
The Pennsylvania Medical Marijuana Program rules and regulations are outlined in a state-specific course, as well.
The Pennsylvania Medical Marijuana Program Required Course Bundle includes two multi-accredited (ACCME, ANCC, ACPE, AANP, APA and AGD PACE credits) courses:
- A Nationally Approved CME/CE Medical Marijuana Course – 3 CME/CE credits
- CBD in Clinical Care – 2 CME/CE credits
And one state-specific course:
- General Information about the Medical Marijuana Act of Pennsylvania
Subscribers can complete the curriculum and refer back to the content at any point during their 12-month subscription period.
Table of Contents:
A Nationally Approved CME/CE Medical Marijuana Course is comprised of 5 lessons:
- Lesson 1: The Endocannabinoid System and Phytocannabinoids
- Lesson 2: Marijuana Products, Modes of Administration and Pharmacology
- Lesson 3: Precautions: The Use of Cannabinoid-based Drugs in Special Patient Populations
- Lesson 4: Precautions: Cannabinoid-based Drug Metabolism and Potential Cannabinoid-based Drug Interactions
- Lesson 5: Physiologic and Cognitive Effects of Marijuana
CBD in Clinical Care is comprised of 4 lessons:
- Lesson 1: CBD Interacts with Multiple Signaling Systems
- Lesson 2: Drug:Drug Interactions, CBD Pharmacology, and CBD Products
- Lesson 3: Clinical Applications
- Lesson 4: The CBD Consumer Should Know
General Information about the Medical Marijuana Act of Pennsylvania:
- Lesson 1: Pennsylvania Rules and Regulations
Meredith Fisher-Corn, MD
This course has been planned and implemented in accordance with the accreditation requirements and policies of multiple accreditation boards. This curriculum offers up to 5.0 hours of ACCME, ANCC, ACPE, AANP, APA and AGD PACE credits. This activity is jointly provided by Global Education Group and The Answer Page, Inc. ACCME, ANCC, ACPE, and AGD accreditation expires May 21, 2023. APA and AANP accreditation expires May 21, 2023. Full accreditation information is available upon purchase.
After completing this activity, the participant should be better able to:
- Describe the endocannabinoid system
- Discuss the components of the endocannabinoid system
- List some of the many functions of the endocannabinoid system
- Define cannabis
- Define marijuana
- Define hemp
- Define phytocannabinoid
- Describe some of the phytocannabinoids
- List a variety of marijuana products
- Describe various modes of marijuana administration
- Describe the pharmacokinetic profile of marijuana for several modes of administration
- Discuss the use of cannabinoid-based drugs in patients with a history of psychotic illness
- Discuss the use of cannabinoid-based drugs in patients with ischemic heart disease
- Discuss the use of cannabinoid-based drugs in patients with hepatic disease
- Discuss the use of cannabinoid-based drugs in patients with a history of drug abuse
- Discuss the use of cannabinoid-based drugs in patients with a hypersensitivity to cannabis-based products
- Discuss the use of cannabinoid-based drugs in obstetric patients
- Discuss the use of cannabinoid-based drugs in pediatric/adolescent patients
- Discuss the use of cannabinoid-based drugs in elderly patients
- List the enzymes responsible for the metabolism of three phytocannabinoids (THC, CBD and CBN)
- Identify clinically significant drug interactions that may occur with cannabinoid-based drugs
- List multiple factors that influence the physiologic and cognitive effects of marijuana
- Discuss the physiologic effects of marijuana
- Discuss the cognitive effects of marijuana
- Describe how marijuana affects CNS function
- Describe how marijuana affects appetite and metabolism
- Describe how marijuana affects gastrointestinal function
- Describe how marijuana affects cardiovascular function
- Describe how marijuana affects the reproductive system
- Describe how marijuana affects the eye
- Describe how cannabidiol (CBD), a cannabis product, interacts with the endocannabinoid system and other receptor systems
- Describe the metabolism of CBD
- List some of CBD’s potential drug:drug interactions
- List the potential adverse events associated with CBD consumption
- Explain the current scientific evidence supporting the clinical use of CBD
Instructions for Obtaining Credit
In order to receive credit, participants must complete all course lessons. Participants must also score at least 70% on each chapter quiz. Upon completion of all lessons and quizzes, you must also complete the evaluation form. Your certificate will be available to download upon completion of the evaluation.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and The Answer Page do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities
TheAnswerPage sends in a weekly report to the PADOH that will include your record of completion.
Practitioners should visit the PADOH website to fulfill the registration requirements.
In order to participate in the Medical Marijuana Program, a physician must:
• First, create a profile in the Department of Health Physician Registration
• A validation of the physician’s Pennsylvania medical license with the Department of State will occur
• Physicians will then be prompted to complete the required 4-hour training provided by a Department of Health approved training entity
• There will be a final review and approval by the Department of Health in order to become a Practitioner who can issue patient certifications